CCL7 and COVID-19: CCL5 is chemotactic for T cells, eosinophils, and basophils expressing the receptor CCR5, and its blockade reduces inflammation and viremia in critically ill COVID-19 patients (Patterson and others 2020), whereas CCL7 attracts monocytes and eosinophils and is associated with the severity of the disease (Yang and others 2020).